TransCode Therapeutics, Inc. (RNAZ) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$1.55
+4.03%
Mkt Cap $8.87M
EPS — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 15, 2026 | — | — | — | -$10.08 | -$18.58 | -84.33% |
| Q4 2025 Nov 14, 2025 | — | — | — | -$9.24 | -$5.49 | +40.58% |
| Q3 2025 Aug 14, 2025 | — | — | — | -$8.68 | -$4.94 | +43.09% |
| Q2 2025 May 14, 2025 | $300.00K | — | — | -$3.21 | -$16.81 | -423.68% |
| Q1 2025 Mar 28, 2025 | $300.00K | — | — | -$105.93 | -$16.61 | +84.32% |
| Q4 2024 Nov 14, 2024 | $300.00K | — | — | -$16.17 | -$5.28 | +67.35% |
| Q3 2024 Aug 14, 2024 | — | — | — | -$19.14 | -$24.42 | -27.59% |
| Q2 2024 May 15, 2024 | — | — | — | -$23.10 | -$21.45 | +7.14% |
| Q1 2024 Mar 29, 2024 | — | $753.15K | — | -$10.80 | -$99.99 | -825.83% |
| Q4 2023 Nov 14, 2023 | — | — | — | -$1980.20 | -$2217.82 | -12.00% |
| Q3 2023 Aug 14, 2023 | — | — | — | -$4475.25 | -$4343.23 | +2.95% |
| Q1 2023 Mar 31, 2023 | — | — | — | -$10033.00 | -$10297.00 | -2.63% |
| Q1 2023 Mar 30, 2023 | — | — | — | -$0.38 | -$0.23 | +39.47% |
| Q4 2022 Nov 14, 2022 | — | — | — | -$10561.10 | -$8712.87 | +17.50% |
| Q3 2022 Aug 15, 2022 | — | — | — | -$0.30 | -$9504.95 | -3168216.67% |
| Q2 2022 May 16, 2022 | — | — | — | — | -$7128.71 | — |
| Q1 2022 Mar 31, 2022 | — | — | — | -$200.00 | -$6072.61 | -2936.30% |
| Q4 2021 Nov 15, 2021 | — | — | — | — | -$5280.53 | — |
| Q3 2021 Aug 23, 2021 | — | — | — | — | $589.73 | — |
| Q3 2021 Jul 9, 2021 | — | — | — | — | -$278.07 | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$100.45 | — |
| Q3 2020 Sep 30, 2020 | — | — | — | — | -$172.19 | — |
| Q2 2020 Jun 30, 2020 | — | — | — | — | -$15.94 | — |
| Q1 2020 Mar 31, 2020 | — | — | — | — | -$6.53 | — |
| Q4 2019 Dec 31, 2019 | — | — | — | — | -$30.53 | — |